Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie E Mueller

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Vaccine|December 27, 2016
A systems approach to vaccine decision makingBruce Y Lee, Leslie E Mueller, Carla G Tilchin
Infection Control and Hospital Epidemiology|March 20, 2018
The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae ToolkitSarah M Bartsch, Susan S Huang, James A McKinnell, et al.
Journal of Clinical Microbiology|September 2, 2016
Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant EnterobacteriaceaeSarah M Bartsch, Susan S Huang, Kim F Wong, et al.
Vaccine|May 25, 2016
The impact of implementing a demand forecasting system into a low-income country's supply chainLeslie E Mueller, Leila A Haidari, Angela R Wateska, et al.
Sexually Transmitted Diseases|November 6, 2020
The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 IndividuallyLindsey Asti, Colin Hopley, Cameron Avelis, et al.
The Journal of Infectious Diseases|June 1, 2019
Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae Carriers Influences TransmissionSarah M Bartsch, Kim F Wong, Owen J Stokes-Cawley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2020
How to Choose Target Facilities in a Region to Implement Carbapenem-resistant Enterobacteriaceae Control MeasuresBruce Y Lee, Sarah M Bartsch, Mary K Hayden, et al.
Plos One|May 30, 2013
Augmenting transport versus increasing cold storage to improve vaccine supply chainsLeila A Haidari, Diana L Connor, Angela R Wateska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2019
How Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a RegionBruce Y Lee, Sarah M Bartsch, Mary K Hayden, et al.
JAMA Network Open|August 4, 2021
Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a RegionSarah M Bartsch, Kim F Wong, Leslie E Mueller, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Vaccine|December 27, 2016
A systems approach to vaccine decision makingBruce Y Lee, Leslie E Mueller, Carla G Tilchin
Infection Control and Hospital Epidemiology|March 20, 2018
The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae ToolkitSarah M Bartsch, Susan S Huang, James A McKinnell, et al.
Journal of Clinical Microbiology|September 2, 2016
Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant EnterobacteriaceaeSarah M Bartsch, Susan S Huang, Kim F Wong, et al.
Vaccine|May 25, 2016
The impact of implementing a demand forecasting system into a low-income country's supply chainLeslie E Mueller, Leila A Haidari, Angela R Wateska, et al.
Sexually Transmitted Diseases|November 6, 2020
The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 IndividuallyLindsey Asti, Colin Hopley, Cameron Avelis, et al.
The Journal of Infectious Diseases|June 1, 2019
Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae Carriers Influences TransmissionSarah M Bartsch, Kim F Wong, Owen J Stokes-Cawley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2020
How to Choose Target Facilities in a Region to Implement Carbapenem-resistant Enterobacteriaceae Control MeasuresBruce Y Lee, Sarah M Bartsch, Mary K Hayden, et al.
Plos One|May 30, 2013
Augmenting transport versus increasing cold storage to improve vaccine supply chainsLeila A Haidari, Diana L Connor, Angela R Wateska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2019
How Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a RegionBruce Y Lee, Sarah M Bartsch, Mary K Hayden, et al.
JAMA Network Open|August 4, 2021
Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a RegionSarah M Bartsch, Kim F Wong, Leslie E Mueller, et al.
Pageof 2